MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on December 12, 2006; DOI: 10.1124/mol.106.029686


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.106.029686v1
71/3/871    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sampey, B. P
Right arrow Articles by Petersen, D. R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sampey, B. P
Right arrow Articles by Petersen, D. R


Received for publication August 7, 2006.
Revised November 13, 2006.
Accepted for publication December 12, 2006.

4-Hydroxy-2-nonenal Adduction of Extracellular Signal-Regulated Kinase and the Inhibition of Hepatocyte Erk-Elk-AP-1 Signal Transduction

Brante P Sampey 1, David L Carbone 2, Jonathan A Doorn 3, Derek A Drechsel 4, Dennis R Petersen 4*

1 University of North Carolina at Chapel Hill 2 Colorado State University 3 University or Iowa 4 University of Colorado at Denver and Health Sciences Center

* Address correspondence to: E-mail: dennis.petersen{at}uchsc.edu

Abstract

4-Hydroxy-2-nonenal (4-HNE) is a major lipid peroxidation (LPO) product formed during oxidative stress. 4-HNE is highly reactive towards cellular nucleophiles and is implicated in the evolution of numerous pathologies associated with oxidative stress and LPO. Recent evidence suggests that chronic pro-oxidant exposure results in the loss of extracellular signal-regulated kinase 1/2 (Erk-1/2) phosphorylation in vivo, a signaling pathway associated with cellular proliferation, survival, and homeostasis. Immunodetection and molecular analysis were used in this study to evaluate the hypothesis that 4-HNE modification of Erk-1/2 inhibits constitutive Erk-Elk-AP1 signaling. Primary rat hepatocytes treated with sub-cytotoxic, pathologically relevant concentrations of 4-HNE demonstrated a concentration-dependent loss of constitutive Erk-1/2 phosphorylation, activity, and nuclear localization. These findings were consistent with iron-induced intracellular LPO, which also resulted in a concentration-dependent decrease in hepatocyte Erk-1/2 phosphorylation and activity. 4-HNE and iron-induced inhibition of Erk-1/2 were inversely correlated with the accumulation of 4-HNE-Erk-1/2 monomer adducts. 4-HNE treatment of hepatocytes decreased nuclear total and phosphorylated Erk-1/2, Elk-1 and AP-1 phosphorylation, as well as cFos and cJun activities. The cytosolic modification of unphosphorylated Erk-1/2 was evaluated in vitro using molar ratios of inactive Erk-2 to 4-HNE consistent with increasing oxidative stress in vivo. Liquid chromatography combined with tandem mass spectrometry (LC-MS/MS) confirmed monomer-adduct formation and identified the major adduct species at the histidine 178 residue within the kinase phosphorylation lip. These novel results show that the formation of 4-HNE-Erk-1/2 monomer-adducts results in the inhibition of Erk-Elk-AP-1 signaling in hepatocytes, and implicates the His 178 residue with the mechanism of inhibition.


Key words: MAP Kinase, Mass Spectroscopy, Regulation - transcriptional, Alcohol, Oxidative stress/antioxidants, Reactive intermediates, Oxidative stress


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
P. A. Grimsrud, H. Xie, T. J. Griffin, and D. A. Bernlohr
Oxidative Stress and Covalent Modification of Protein with Bioactive Aldehydes
J. Biol. Chem., August 8, 2008; 283(32): 21837 - 21841.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics